The devicemaker’s core spine, motion preservation and EBI bone healing portfolios will be sold off to “create a leaner, more focused ZimVie with a leading position in attractive and growing global dental markets,” CEO Vafa Jamali said in a Dec. 18 news release.
ZimVie’s stock shares rose 40% early Dec. 18 amid news of the sale, Seeking Alpha reported. The transaction is expected to close in the first half of 2024.
Zimmer Biomet’s spine and dental businesses split off through ZimVie in 2022. This year, ZimVie’s spine sales saw year-over-year sales decreases in the first, second and third quarters.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
